Generic Drug Price-Fixing Suits Just Tip Of The Iceberg

Law360, Fort Wayne (January 6, 2017, 2:36 PM EST) -- The U.S. Department of Justice and state attorneys general have sued generic drug companies and executives over allegations of price-fixing and market-sharing, and experts expect the fray to greatly expand in 2017, encompassing many more individuals and companies and possibly growing beyond manufacturers.

The charges leveled against two former Heritage Pharmaceuticals Inc. executives were the first to result from the DOJ’s two-year investigation into the industry. They came one day before 20 states filed a civil suit against Heritage and five other generic drug companies, including...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.